← Open Payments lookup

LAUREN LUTZ: Open Payments

NPI 1417407743 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$76,129 in 279 payments from 19 companies in 2025. Trend: 2023 $107,839 · 2024 $93,992 · 2025 $76,129

Honoraria: $30,313Speaker / faculty: $27,775Travel & lodging: $7,312Consulting: $5,849Food & beverage: $4,671Education: $209
CompanyPaymentsAmount
Axsome Therapeutics, Inc.69$34,878
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$14,924
Alkermes, Inc.39$11,057
E.R. Squibb & Sons, L.L.C.31$7,831
Vanda Pharmaceuticals Inc.30$6,171
Neurocrine BioSciences, Inc.20$239
Teva Pharmaceuticals USA, Inc.8$238
Supernus Pharmaceuticals, Inc.16$197
Otsuka America Pharmaceutical, Inc.16$188
Lundbeck LLC4$76

Products named: Auvelity, CAPLYTA, LYBALVI, COBENFY, FANAPT, INGREZZA, Qelbree, ARISTADA.

Industry payments across IN — which companies pay providers there.